Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Brazilian National Cancer Institute, Rio de Janeiro, Brazil

© Carlos Gil Ferreira

Dr Ferreira graduated in Medicine from the Federal University of Juiz de Fora (1992) and completed his PhD in Experimental Oncology at the Free University of Amsterdam (2001).

From 2002 to 2015 he was a senior researcher and head of the Clinical Research Service of the National Cancer Institute (INCA), where he held the following positions: Head of the Clinical Research Division, Head of the Scientific Program of Clinical Research, Creator and Principal Investigator of the National Tumor Bank and DNA (BNT), Coordinator of the National Network of Drug Development Anticancer (REDEFAC/SCTIE/MS) and Coordinator of the National Network of Clinical Research on Cancer (RNPCC/SCTIE/MS). Since 2015 Dr Ferreira has been the Research Coordinator in Oncology D’Or Institute for Research and Education.

Outside of his institutional work, Dr Ferreira holds the following positions: Member of the Scientific Committee (CCVISA) of the National Health Surveillance Agency (ANVISA); Chair of the Latin American Oncology Consortium (LAOC), Co-Chair of the Career Development Fellowship Committee and the International Association for the Study of Lung Cancer (IASLC); Member of the International Affairs Committee of the American Association for Cancer Research (AACR); Director in Brazil of the International Network for Cancer Treatment and Research (INCTR); and Member of the Advisory Committee Americas Health Foundation (AHF). Dr Ferreira has a particular interest in health innovation projects, having worked with the government and commercial sectors in projects related to the development of diagnostic kits, new drugs and health economics.